<DOC>
	<DOC>NCT00713427</DOC>
	<brief_summary>This is a a prospective study of the WallFlex™ Biliary Partially-covered Stent designed to collect data to support regulatory clearance by the FDA in the United States and to determine the functionality of the WallFlex™ Biliary Partially Covered Stent as a Palliative treatment for malignant bile duct obstruction.</brief_summary>
	<brief_title>Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>Age 18 years or older Inoperable extrahepatic biliary obstruction by any malignant process Indicated for metal stent placement for palliative treatment of biliary stricture(s) produced by malignant neoplasms Willing and able to comply with the study procedures and provide written informed consent to participate in the study Participation in another invesitgational study within 90 days prior to date of patient consent. Strictures that cannot be dialated enough to pass the delivery system Perforation of any duct within the biliary tree Presence of any esophageal or duodenal stent Patients for whom endoscopic procedures are contraindicated Patients with known senesitivity to any components of the stent or delivery system Patients with active hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Biliary</keyword>
	<keyword>Strictures</keyword>
	<keyword>Malignant</keyword>
	<keyword>Neoplasm</keyword>
	<keyword>Palliation</keyword>
</DOC>